NACCME/Princeton CMENACCME/Princeton CME
First ReportManaged Care ConsultantCoalition of Rheumatology Educators (CORE)CME ForumCE ForumNP/PA ConsultantPrinceton Teleconference Series

Testing Center


CORE Programs
WorkShops
Symposiums
Teleconferences
Textbook
Video
Newsletters
Audio
Discuss the Latest Rheumatic Disease Issues With Expert Faculty and Peers
Discuss the Latest Rheumatic Disease Issues With Expert Faculty and Peers
Discuss the Latest Rheumatic Disease Issues With Expert Faculty and Peers
Discuss the Latest Rheumatic Disease Issues With Expert Faculty and Peers
Discuss the Latest Rheumatic Disease Issues With Expert Faculty and Peers
Symposiums
Teleconferences

Current Strategies for the Diagnosis, Management, and Assessment of the Spondyloarthropathies

Register Now

Register now for the educational teleconference “Current Strategies for the Diagnosis, Management, and Assessment of the Spondyloarthropathies,” which provides up-to-date clinical data and the opportunity to pose questions to 2 expert CORE™ faculty members during live Q&A sessions. This activity addresses initial methods to identify and diagnose the spondyloarthropathies (SpAs), as well as subsequent outcome measures of disease activity. Also discussed are the latest data on the benefits and limitations of biologic therapies in the treatment of SpAs and strategies to assess the management of these conditions.

 

Testimoials

The course was well prepared and presented information that was important for physicians. I was able to ask questions in a very relaxed atmosphere and receive answers that were practical and insightful. The opportunity to learn from experienced clinicians in a small group was wonderful.
—Robert Carpenter, MD, FACP, practicing rheumatologist, Chicago, IL

The American Academy of CME designates each chapter of this educational activity for a maximum of 1.25 (total maximum 13.75) AMA PRA Category 1 Credits™.

To view the CORE textbook online, click on the individual chapters.

Chapter

 

 

Introduction

1

Pathogenesis of Rheumatoid Arthritis and its Implications for Therapy—The Need for Early/Aggressive Therapy

2

Assessing Disease Status and Treatment Efficacy: Biomarkers and Clinical Measures of Rheumatoid Arthritis

3

Therapies and Management Strategies for Improved Outcomes in Rheumatoid Arthritis

4

Safety of Biologics in the Treatment of Rheumatoid Arthritis

5

Managing Comorbidities in Rheumatoid Arthritis

6

Juvenile Rheumatoid Arthritis—An Update in Management

7

Emerging Approaches: Review of Data on Newer Investigational Therapies for RA

8

Update on the Spondyloarthropathies and Advances in Treatment for Psoriatic Arthritis Reactive Arthritis, and Arthritis Associated with Inflammatory Bowel Disease

9

Advancing Effective Ankylosing Spondylitis Management

10

The Rationale for Biologic Therapy in Psoriasis: A New Therapeutic Option

11

Emerging Role of Biologic Therapy in Systemic Lupus Erythematosus

Video

4 Video Webcasts Totaling 2 CME Credits

Core Video Webcasts

Current Opportunities for Improving Patient Outcomes in Rheumatoid Arthritis

Participate in the interactive, educational Webcast “Current Opportunities for Improving Patient Outcomes in Rheumatoid Arthritis,” which discusses pertinent issues within rheumatoid arthritis, including the efficacy and safety of biologic therapies, the goal of reaching disease remission, and managing rheumatoid arthritis-related comorbidities.

View the Webcast


CORE


This is the second in a series of CORE newsletters titled “Managing Comorbidities in Rheumatoid Arthritis.” The newsletter discusses the connection between uncontrolled rheumatoid arthritis and the development of comorbid conditions and incorporates evidence-based approaches for the prevention and management of treatment adverse effects and rheumatoid arthritis-related comorbidities.

Managing Comorbidities in Rheumatoid Arthritis


CORE


This is the first in a series of CORE newsletters titled “Reaching the Goal of Remission in Rheumatoid Arthritis.” The newsletter discusses the concept of remission, whether patients with rheumatoid arthritis are reaching remission, and the various measurements and biomarkers currently used to assess remission status.

Reaching the Goal of Remission in Rheumatoid Arthritis

Getting to Remission: Measurements vs Biomarkers vs Better Drugs

On-demand Audio

Managing Comorbidities in Rheumatoid Arthritis

On-demand Audio

Safety and Efficacy of Biologics in Rheumatoid Arthritis

On-demand Audio

Coalition of Rheumatology Educators (CORE)

The Coalition of Rheumatology Educators (CORE™) initiative is designed to enhance rheumatologists’ awareness of the need for early diagnosis and aggressive management of rheumatoid arthritis (RA) and the spondyloarthropathies and to better objectify assessment of disease activity, potentially leading to remission. Clinical experts in the field of rheumatology have developed educational content based on the latest published and presented data for live, print, and web-based CME programming in 2007 and will continue to work to develop content for live, print, and web-based CME programming in 2008, and to assess participant learning and ongoing educational needs.

CORE Faculty Members

Clifton O. Bingham III, MD
Assistant Professor of Medicine
Division of Rheumatology, Department of Medicine
Johns Hopkins University
Baltimore, Maryland

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic Foundation
Cleveland, OH

John C. Davis, Jr., MD, MPH
Associate Professor of Medicine
University of California, San Francisco
San Francisco, California

Richard A. Furie, MD
Chief, Division of Rheumatology and Allergy-Immunology
North Shore-Long Island Jewish Health System
Lake Success, New York

Allan Gibofsky, MD*
Professor of Medicine and Public Health
Weill Medical College of Cornell University
New York, New York

Diana Goldenberg, MD, MPH
Hospital for Special Surgery
Weill Medical College of Cornell University
New York, New York

John A. Goldman, MD, FACR, FACP, CCD
Private Practice
Chief of Rheumatology
St. Joseph’s Hospital
President, Medical Quarters
Atlanta, Georgia

Kathryn F. Hobbs, MD
Associate Clinical Professor of Medicine
University of Colorado Denver
Director, Clinical Trials Unit
Denver Arthritis Clinic
Denver, Colorado

Arthur Kavanaugh, MD
Professor of Clinical Medicine
Director, Center for Innovative Therapy
Division of Rheumatology, Allergy, and Immunology
University of California San Diego School of Medicine
La Jolla, California

Jonathan Kay, MD
Director of Clinical Trials, Rheumatology Unit
Massachusetts General Hospital
Associate Clinical Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Edward Keystone, MD
Professor of Medicine, University of Toronto
Director, The Rebecca MacDonald Centre for Arthritis and Autoimmune Disease
Director, Division of Advanced Therapeutics in Arthritis
Mount Sinai Hospital
Toronto, Ontario, Canada

Muhammad A. Khan, MD, MACP, FRCP
Professor of Medicine
Case Western Reserve University
Cleveland, Ohio

Joel M. Kremer, MD
Pfaff Family Professor of Medicine
Albany Medical College
Director of Research
The Center for Rheumatology
Albany, New York

Carlos J. Lozada, MD
Associate Professor of Clinical Medicine
University of Miami Miller School of Medicine
Miami, Florida

Joseph A. Markenson, MD
Professor of Clinical Medicine
Weill Medical College of Cornell University
New York, New York

Philip J. Mease, MD*
Seattle Rheumatology Associates
Chief of Rheumatology Research
Swedish Medical Center
Clinical Professor of Medicine
University of Washington
Seattle, Washington

Eleanor Mody, MD
Director, Center for Skin and Related Musculoskeletal Conditions
Brigham and Women’s Hospital
Instructor of Medicine, Harvard Medical School
Boston, Massachusetts

Stephen A. Paget, MD
Professor of Medicine
Weill Medical College of Cornell University
New York, New York

Andreas Reiff, MD
Associate Professor of Pediatrics
Chief, Division of Pediatric Rheumatology and Rehabilitation
USC Keck School of Medicine
Childrens Hospital
Los Angeles, California

Christopher Ritchlin, MD
Professor of Medicine
Director, Clinical Immunology Research Center
Allergy, Immunology, and Rheumatology Division
University of Rochester Medical Center
Rochester, New York

Eric M. Ruderman, MD*
Associate Professor of Medicine
Division of Rheumatology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Sergio Schwartzman, MD
Associate Professor of Clinical Medicine
Weill Medical College of Cornell University
The Hospital for Special Surgery
New York Presbyterian Hospital
New York, New York

Vibeke Strand, MD, FACP
Adjunct Clinical Professor of Medicine
Division of Immunology & Rheumatology
Stanford University
Stanford, CA

Bruce E. Strober, MD, PhD
Assistant Professor
Associate Director of the Dermatology Clinical Trials Unit
NYU School of Medicine
Co-Director, Psoriasis and Psoriatic Arthritis Center
New York University Hospital
New York, New York

S. Bobo Tanner, MD
Assistant Professor of Medicine
Director, Osteoporosis Clinic
Divisions of Rheumatology, Allergy, & Immunology
Vanderbilt University Medical Center
Nashville, Tennessee

John R. P. Tesser, MD
Practicing Rheumatologist
Arizona Arthritis & Rheumatology Associates, P.C.
Clinical Lecturer
University of Arizona College of Medicine
Paradise Valley, Arizona

Arthur L. Weaver, MD
Clinical Professor Emeritus
Department of Medicine, Section of Rheumatology
University of Nebraska Medical Center
Omaha, Nebraska

Michael H. Weisman, MD
Professor of Medicine
UCLA School of Medicine
Los Angeles, California  

Alvin F. Wells, MD, PhD
Director, Rheumatology and Immunotherapy Center
Oak Creek, Wisconsin
Clinical Assistant Professor
Rosalind Franklin University of Medicine and Sciences
N. Chicago, Illinois
Adjunct Assistant Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Yusuf Yazici, MD
Assistant Professor of Medicine
New York University School of Medicine
Director, Seligman Center for Advanced Therapeutics
NYU Hospital for Joint Diseases
New York, New York

2008 Chair, Advisory Board, CORE
Content Development

Marc D. Cohen, MD
Professor of Medicine
National Jewish Medical and Research Center
Denver, Colorado

* 2008 Advisory Board, CORE Content Development


Grant Support

CORE™ is supported by educational grants from Genentech, Inc and Biogen Idec Inc, Abbott Laboratories, Centocor, Inc, UCB, Inc, Bristol-Myers Squibb Company, and Amgen Inc and Wyeth Pharmaceuticals.


   

©Copyright 2003-2008 NACCME-Princeton CME   Privacy Policy
Hardware/Software Requirements Disclosure Statement